GlassScriptPhysician profile
Miles Durham
NPI 1841744018
$1,209.46
in general payments reported to CMS, 2019-2025
15 companies · $65.36 in 2025
The $65.36 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $772 · 2022: $212 · 2023: $51.37 · 2024: $109 · 2025: $65.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $599.24 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $168.55 | 2021-2023 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $95.76 | 2021 | |
| Amgen INC. | $54.25 | 2021-2024 | Evenity, Prolia |
| Medtronic, INC. | $48.66 | 2022 | |
| Depuy Synthes Sales INC. | $41.93 | 2024-2025 | Monovisc, Orthovisc |
| Vertex Pharmaceuticals Incorporated | $39.24 | 2025 | |
| Endo USA, INC. | $33.81 | 2024 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $27.39 | 2022 | |
| Kci USA, INC. | $23.48 | 2022 | |
| Abbvie INC. | $22.52 | 2024 | |
| Endo Pharmaceuticals INC. | $19.47 | 2023 | Xiaflex |
| Solventum Corporation | $15.59 | 2024 | Prevena Restor Axioform, Prevena Restor Arthroform, Promogran Prisma |
| Avanos Medical | $12.27 | 2022 | |
| Orthofix Medical, INC. | $7.30 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.